Rani Therapeutics Holdings (RANI) Payables (2020 - 2026)
Rani Therapeutics Holdings' Payables came in at $1.05 million for Q2 2026, down 41.7% from $1.8 million a year earlier but up 22.3% from the prior quarter.
Powered by 
Analysis
Rani Therapeutics Holdings (RANI) Payables (2020 - 2026) Analysis & Trends
At the end of FY2025, Rani Therapeutics Holdings' Payables was $309,000, down 77.3% from FY2024.
- Payables carries a five-year compound annual growth rate of -10.5% (FY2020 to FY2025).
- Going back by year, Payables was $1.36 million in FY2024 (+109.7%), $648,000 in FY2023 (-55.6%), $1.46 million in FY2022 (+35.2%) and $1.08 million in FY2021 (+101.1%).
- The five-year range for quarterly Payables is $309,000 (Q4 2025) to $2.47 million (Q3 2025).
- Year-over-year, Payables has declined for three consecutive quarters, with growth averaging 45.0% over the last eight quarters.
- The fastest year-over-year change in Payables over five years came in Q2 2025 (growth of 255.3%), and the weakest in Q4 2025 (a decline of 77.3%).
- Business Quant data shows RANI's Payables at $858,000 (Q1 2026), $309,000 (Q4 2025) and $2.47 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Rani Therapeutics Holdings | 147.86 Mn | 156.61 Mn | - | 1.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.05 Mn |
| Mar 31, 2026 | 858,000.00 |
| Dec 31, 2025 | 309,000.00 |
| Sep 30, 2025 | 2.47 Mn |
| Jun 30, 2025 | 1.80 Mn |
| Mar 31, 2025 | 1.52 Mn |
| Dec 31, 2024 | 1.36 Mn |
| Sep 30, 2024 | 1.57 Mn |
| Jun 30, 2024 | 506,000.00 |
| Mar 31, 2024 | 806,000.00 |
| Dec 31, 2023 | 648,000.00 |
| Sep 30, 2023 | 1.41 Mn |
| Jun 30, 2023 | 1.04 Mn |
| Mar 31, 2023 | 1.51 Mn |
| Dec 31, 2022 | 1.46 Mn |
| Sep 30, 2022 | 1.79 Mn |
| Jun 30, 2022 | 1.44 Mn |
| Mar 31, 2022 | 1.27 Mn |
| Dec 31, 2021 | 1.08 Mn |
| Sep 30, 2021 | 1.31 Mn |
API Access
Rani Therapeutics Holdings Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=RANI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "RANI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=RANI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();